The Japanese medtech giant’s Terumo Interventional Systems division designed the R2P NaviCross catheter for optimized performance in R2P procedures, which involve accessing the radial artery around the wrist in order to conduct procedures in peripheral vasculature such as the legs.
Now available in a 200 cm length, the R2P NaviCross catheter is double-braided, stainless-steel construction is meant to provide superior trackability and torque control for lesion crossing in more complex procedures, according to a Terumo news release posted yesterday.
“Our customers have been asking for a longer length, high-performance NaviCross support catheter, and I am proud to say we answered the need by delivering R2P NaviCross to the market, further enhancing our radial-to-peripheral portfolio,” Ghada Farah, division president of Terumo Interventional Systems, said in the news release. “R2P NaviCross solidifies Terumo’s leadership in radial access, particularly as the demand for procedures to treat peripheral artery disease (PAD) and critical limb ischemia continues to rise.”
Said Dr. Michael J. Martinelli, chief medical officer of Terumo Medical Corp.: “With the 200 cm length, the R2P NaviCross catheter provides physicians performing percutaneous transluminal endovascular procedures from the radial artery a valuable tool to enhance their ability to safely and efficiently complete more procedures from a radial approach. Additionally, the double-braided, stainless-steel design of the R2P NaviCross catheter makes it possible to access and cross simple-to-complex lesions above and below the knee.”
The 200 cm R2P NaviCross catheter complements the existing R2P portfolio, including the R2P Destination Slender guiding sheath, R2P SlenGuide guiding catheter, R2P Misago self-expanding peripheral stent, and R2P Metacross RX and R2P Crosstella RX dilatation catheters.
